Skip to content

Peripheral Nerve Stimulation for Treatment of Sacroiliac Joint Pain

Peripheral Nerve Stimulation for Treatment of Chronic Therapy-refractory Sacroiliac Joint Pain

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05357300
Acronym
SIlencing
Enrollment
90
Registered
2022-05-02
Start date
2022-04-26
Completion date
2025-04-30
Last updated
2022-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sacroiliac Joint Pain

Keywords

Peripheral Nerve Stimulation, Back Pain, Sacroiliac Joint Pain, Neuromodulation, Persistent Spinal Pain Syndrome

Brief summary

Prospective randomized controlled study, primary objective: Pain reduction in patients with chronic Sacroiliac joint pain after therapy either with Peripheral Nerve Stimulation or with best medical treatment. Randomization 4:3 to operative (PNS=Peripheral Nerve Stimulation) arm or conservative (BMT= Best Medical Treatment) arm with crossover possibility for the BMT group after 6 months.

Interventions

DEVICEPeripheral Nerve Stimulation

Implant of percutaneous leads for peripheral nerve stimulation of the rami dorsales of the SIJ and gluteal or abdominal implant of impulse generator

Sponsors

PD Dr. med. Simon Bayerl
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Evaluation of the pain reduction in patients treated with peripheral nerve stimulation compared to best medical treatment

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is at least 18 years old * Subject with chronic sacroiliac joint pain refractory to conservative treatment * Subject with NRS of at least 60/100 * Subject with temporary pain reduction of at least 50% (NRS) after fluoroscopy guided SIJ infiltration * Subject received conservative treatment for at least three months including physiotherapy and pain medication * Subject is able to understand the study and Impulse generator programming

Exclusion criteria

* Pregnancy * Subject is under age * Acute traumatic injury of the ISG * Active inflammation or neoplastic infiltration of the SIJ * Neoplastic diseases of the spine * Spinal surgery within the last three months * The SIJ pain is not the leading symptom * Contraindication for Neuromodulation Device (severe psychiatric disease, severe coagulation disorder, acute infection, active autoimmune disease with immunosupression)

Design outcomes

Primary

MeasureTime frameDescription
Change of chronic sacroiliac joint pain6 monthsChange of pain measured with a numeric rating scale ranking from minimum 0 to maximum 100 where higher numbers mean a worse outcome

Countries

Germany

Contacts

Primary ContactSimon H Bayerl, MD
simon.bayerl@charite.de+49 (0)30 450 560789
Backup ContactDimitri Tkatschenko, MD
dimitri.tkatschenko@charite.de+49 (0)30 450 560789

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026